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cense.Abstract QSAR analysis on a series of 13 derivatives of 5-hydroxy-3-(2H)-pyridazinone as hepa-
titis C virus NS5B polymerase inhibitors was performed. The inhibitory activities of these com-
pounds were found to increase with density (D), index of refractivity (Ior), surface tension (St),
electronegativity (Xeq) and decrease with the balaben centric index (Bac), balaben distance connec-
tivity index (J) and zero order connectivity (X0) along with the indicator parameter. Excellent
results were obtained from regression upon introduction of the indicator parameter. The results
are critically discussed on the basis of regression data and cross validation technique.
ª 2010 King Saud University. Open access under CC BY-NC-ND license.1. Introduction
Hepatitis C virus (HCV) causes chronic liver diseases. Infected
people will develop chronic histological changes in the liver
with a high risk of advancing to cirrhosis or hepatocellular car-
cinoma (Wong and Lee, 2006). The treatment against HCV is a
combination therapy of pegylated interferon and ribavirin.
Unfortunately, this treatment has 50% beneﬁts and is associ-
ated with adverse events. Therefore there is an urgent need
for the development of effective HCV therapies.iffmail.com (A.K. Srivastava),
y), akanchha_au@rediffmail.
@rediffmail.com (N. Shukla).
ity.
lsevierWith this rational in mind, we describe herein the quantita-
tive structure activity relationship (QSAR) studies of a series
of HCV NS5B polymerase inhibitors (Zhou et al., 2008), aim-
ing at identifying the physicochemical properties that govern
the inhibitory activity of HCV NS5B polymerase inhibitors.
It is envisioned that these studies will produce models that
can be used for future designing of new analogues with higher
potency.2. Results and discussion
QSAR studies were performed on the compounds listed in
Table 1, where the biological activity IC50 is a measure of
inhibitory activity. All the QSAR reported herein were derived
by us and were not reported with the original data set taken
from the literature as reference. We have used Hansch analysis
for developing these models.
An attempt has been made to correlate the activities of the
compounds with physicochemical parameters such as density
(D) (Acd-Lab software), index of refraction (Ior) (Acd-Lab
software), surface tension (St) (Acd-Lab software) and electro-
negativity (Xeq) (Acd-Lab software) for a set of HCV NS5B
Table 1 Biological activity and physicochemical data for HCV NS5B polymerase inhibitors.
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S. No. R1 R2 D Ior St Bac J X
0 Xeq I1 pIC50
1
S
1.590 1.730 68.700 77 1.495 25.328 2.423 0 6.469
2
S
1.720 1.800 81.500 40 1.301 24.742 2.437 0 7.000
3
S
1.530 1.708 65.200 94 1.502 26.250 2.412 1 6.620
4
S
1.500 1.697 63.400 94 1.524 26.250 2.403 0 6.004
5
S
1.550 1.717 66.600 78 1.492 26.035 2.412 0 6.000
6
S
1.560 1.719 67.100 91 1.518 25.543 2.423 0 6.076
7
S
1.720 1.800 81.500 40 1.312 24.742 2.437 0 6.268
8
S
1.620 1.766 75.400 40 1.315 26.156 2.453 0 6.268
9
S
1.720 1.800 81.500 40 1.301 24.742 2.437 0 6.921
10
S
1.720 1.800 81.500 40 1.301 24.742 2.437 0 6.854
11
N
S
1.650 1.753 73.100 77 1.495 25.328 2.437 0 6.824
12
N
S
1.790 1.830 87.400 40 1.301 24.742 2.451 0 6.854
13 1.420 1.649 55.500 128 1.742 25.913 2.379 0 5.292
26 A.K. Srivastava et al.polymerase inhibitors were calculated by Acd-Lab Chem
Sketch software. The balaben centric index (Bac) (DRAGON
software), balaben distance connectivity index (J) (DRAGON
software) and zero order connectivity (X0) (DRAGON soft-
ware) for a set of HCV NS5B polymerase inhibitors were cal-
culated by DRAGON software.
Indicator parameter is the dummy parameter sometimes
used for accounting those structural features not covered in
any molecular descriptor used. The details of such parameter,
used in the present study are given in the results and discussion
section (Table 1). The multiregression analysis used to derivethe correlation was executed with SPSS (7.5) program. Ini-
tially, we have used the Pogliani’s quality factor Q for investi-
gating predictive power of the various parameters and ﬁnally,
the cross validation techniques to prove our ﬁndings.
The series of HCV NS5B polymerase inhibitors, their inhib-
itory activities, physicochemical parameters and indicator
parameter are reported in Table 1.
The autocorrelation between the used parameters was
checked and is shown in Table 2. The results show that all
the physicochemical parameters are orthogonal and can be
subjected to multiregression analysis with indicator parameter.
Table 3 Predicted and residual values for Eq. (1).
S. No. Observed Predicted Residual
1 6.469 6.27 0.198
2 7 6.861 0.139
3 6.62 6.62 0
4 6.004 5.861 0.143
5 6 6.088 0.088
6 6.076 6.134 0.058
7 6.268 6.861 
8 6.268 6.406 0.139
9 6.921 6.861 0.06
10 6.854 6.861 0.007
11 6.824 6.543 0.281
12 6.854 7.179 0.325
13 5.292 5.498 0.205
Figure 1 A Plot of comparison between observed and predicted
activities for Eq. (1).
Table 2 Autocorrelation matrix between physicochemical and indicator parameters.
I1 D Ior St Bac J X
0 Xeq
I1 1.000
D 0.243 1.000
Ior 0.233 0.992 1.000
St 0.235 0.992 0.999 1.000
Bac 0.256 0.916 0.954 0.948 1.000
J 0.140 0.902 0.945 0.939 0.985 1.000
X0 0.384 0.842 0.794 0.797 0.654 0.612 1.000
Xeq 0.192 0.878 0.899 0.892 0.905 0.893 0.557 1.000
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pIC50 ¼ 4:544ð1:251ÞDþ 0:622ð0:473ÞI1  0:955 ð1Þ
n ¼ 12;R ¼ 0:940;R2 ¼ 0:884;R2A ¼ 0:858; SE ¼ 0:194;
F½2;9 ¼ 34:261;Q ¼ 4:845
pIC50 ¼ 9:075ð2:946ÞIorþ 0:595ð0:544ÞI1  9:476 ð2Þ
n ¼ 12;R ¼ 0:920;R2 ¼ 0:846;R2A ¼ 0:811; SE ¼ 0:224;
F½2;9 ¼ 24:654;Q ¼ 4:107
pIC50 ¼ 0:051ð0:017ÞStþ 0:597ð0:570ÞI1 þ 2:699 ð3Þ
n ¼ 12;R ¼ 0:912;R2 ¼ 0:831;R2A ¼ 0:794; SE ¼ 0:234;
F½2;9 ¼ 22:192;Q ¼ 3:897
pIC50 ¼ 0:015ð0:007ÞBacþ 0:605ð0:732ÞI1 þ 7:446 ð4Þ
n ¼ 12;R ¼ 0:851;R2 ¼ 0:724;R2A ¼ 0:663; SE ¼ 0:300;
F½2;9 ¼ 11:814;Q ¼ 2:837
pIC50 ¼ 3:166ð3:028ÞJþ 0:417ð1:449ÞI1 þ 10:958 ð5Þ
n ¼ 12;R ¼ 0:847;R2 ¼ 0:717;R2A ¼ 0:654; SE ¼ 0:304;
F½2;9 ¼ 11:403;Q ¼ 2:786
pIC50 ¼ 0:719ð0:768ÞX0 þ 0:809ð1:677ÞI1 þ 24:692 ð6Þ
n ¼ 12;R ¼ 0:819;R2 ¼ 0:670;R2A ¼ 0:597; SE ¼ 0:328;
F½2;9 ¼ 9:151;Q ¼ 2:497
pIC50 ¼ 20:200ð21:062ÞXeqþ 0:491ð1:553ÞI1  42:602 ð7Þ
n ¼ 12;R ¼ 0:825;R2 ¼ 0:681;R2A ¼ 0:610; SE ¼ 0:322;
F½2;9 ¼ 9:600;Q ¼ 2:562
In all the models, the statistical parameter ‘n’ is the number
of data points, ‘R’ is the correlation coefﬁcient, ‘R2’ is the coef-
ﬁcient of determination, ‘R2A’ is the adjusted R
2, ‘SE’ is the
standard error of estimate, ‘F’ is the F ratio (Diudea, 2000;
Bikash et al., 2003), ‘Q’ is the quality of ﬁt (Pogliani, 1994;
Pogliani, 1996), and data within the parenthesis is the conﬁ-
dence interval at 95% level. Compound number 7 is treated
as outlier since this compound having a benzyl R2 substituent
displayed a weaker antiviral potency.
From the above regression equations, it is clear that the
coefﬁcients of D, Ior, St and Xeq are positive which indicate
that denser, bulkier and more electronegative groups are ben-
eﬁcial for the activity. The negative coefﬁcients of Bac and J
indicate that they have a negative effect on the inhibitory activ-
ity. The negative coefﬁcient of X0 suggests that less zero order
branching is favorable. The indicator I1 for group at R
2
site has positive coefﬁcient indicating thereby this group shows
a positive inﬂuence in determining the activity. The robustness
and applicability of the above QSAR equations were furtherconﬁrmed by the cross validation technique like leave one
out method (Cramer et al., 1988; Podlgar and Ferguson, 2000).
Predicted and residual values for the derived QSAR models
are given in Table 3. Predicted values are the calculated activ-
ities of the equation and the residual values are the differences
between the observed biological activities and the calculated
activities and are found to be low. The calculated F value is
greater than F theoretical value (F[2,9] = 4.26) for all the signif-
icant equation. The plot of observed pIC50 versus predicted
Table 4 Cross validation parameters and predictive error of coefﬁcient of correlation (PE) for the proposed models.
Eq. No. n Parameter PRESS SSY PRESS/SSY R2cv PSE R 1-R
2 PE 6PE
Eq. (1) 12 D+ I1 0.340 2.590 0.131 0.869 0.168 0.940 0.116 0.022 0.134
Eq. (2) 12 Ior + I1 0.452 2.478 0.182 0.818 0.194 0.920 0.154 0.030 0.178
Eq. (3) 12 St + I1 0.494 2.436 0.203 0.797 0.203 0.912 0.168 0.032 0.194
Eq. (4) 12 Bac + I1 0.808 2.122 0.381 0.619 0.259 0.851 0.276 0.053 0.318
Eq. (5) 12 J+ I1 0.829 2.101 0.395 0.605 0.263 0.847 0.283 0.054 0.324
Eq. (6) 12 X0 + I1 0.966 1.964 0.492 0.508 0.284 0.819 0.329 0.063 0.378
Eq. (7) 12 Xeq + I1 0.935 1.995 0.469 0.531 0.279 0.825 0.319 0.061 0.366
28 A.K. Srivastava et al.pIC50 based on the Eq. (1) is shown in graph (Fig. 1) and the
predicted R2 was found to be fairly large.
Where, observed activities are the biological activities IC50,
which are measures of inhibitory activities, predicted values
are the calculated activities of the equations and residual val-
ues are the differences between the observed biological activi-
ties and the calculated activities.
2.1. Cross validation
The cross validation analysis was performed using leave one
out (LOO) method (Cramer et al., 1988; Podlgar and Ferguson,
2000), in which one compound is removed from the data set
and the activity is correlated using the rest of the data set.
The cross-validated R2 was found to be very close to the value
of R2 for the entire data set and hence these models can be
termed as statistically signiﬁcant.
Cross validation provides the values of PRESS, SSY and
R2cv and PSE from which we can test the predictive power of
the proposed model. The meanings of these cross-validated
parameters are given as a footnote to the Table 4. It is argued
that PRESS is a good estimate of the real predictive error of
the model and if it is smaller than SSY the model predicts bet-
ter than chance and can be considered statistically signiﬁcant.
Furthermore, the ratio PRESS/SSY can be used to calculate
approximate conﬁdence intervals of prediction of new com-
pound. To be a reasonable QSAR model PRESS/SSY should
be smaller than 0.4 and for our models the value of this ratio
which is smaller than 0.1 indicates that they are excellent mod-
els. Also, if PRESS value is transformed in a dimensionless
term by relating it to the initial sum of squares, we obtain
R2cv i.e. the complement to the traces of unexplained variance
over the total variance. The PRESS and R2cv have good prop-
erties. However, for practical purposes of end users the use of
square root of PRESS/n, which is called predictive square
error (PSE), is more directly related to the uncertainty of the
predictions. The PSE values also support our results. The
calculated cross-validated parameters conﬁrm the validity of
the models.
2.2. Predictive error of coefﬁcient of correlation (PE)
The predictive error of coefﬁcient of correlation (PE) (Chaterjee
et al., 2000) is yet another parameter used to decide the predic-
tive power of the proposed models. We have calculated PE
value of all the proposed models and they are reported in
Table 4. It is argued that ofi) R< PE, then correlation is not signiﬁcant;
ii) R> PE; several times (at least three times), then corre-
lation is indicated; and if
iii) R> 6PE, then the correlation is deﬁnitely good.
For all the models developed the condition R> 6PE and
hence they can be said to have good predictive power.
The data presented in Table 4 indicate that in all the cases,
R is much larger than 6PE indicating that all the proposed
models have represented high degree of correlation.
3. Conclusions
On the basis of the above discussions two general conclusions
can be drawn as below.
i) More denser, more bulkier and more electronegative
groups with less branching should be used in the future
drug modeling.
ii) The indicator I1 for group at R
2 site is preferen-
tially favorable.
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